Conversations about cholesterol seem almost impossible to avoid-especially as we get older. But, according to experts there ...

Very low bad (LDL) cholesterol may increase future risk of diabetes even in people who do not take statins. LDL-C could be a warning sign for metabolic imbalance.

New review shows statins remain first-line therapy in MASLD, while PCSK9 inhibitors offer potential but require more evidence. Learn more about evolving treatment guidance.

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Teresa Carr Vitamin prices ...

Enlicitide is an investigational oral PCSK9 inhibitor that has shown substantial reductions in LDL-C levels in patients with ...

Developed by researchers at Oxford University, the technology has been described by cardiologists as the “best predictor of a ...

Many believe a morning drink of warm water with garlic and lemon can lower cholesterol. While some studies show promise for ...

A statin isn’t the only answer anymore to lowering cholesterol. The lipid-reducing medicines, among the most widely prescribed drugs in the U.S., have been a mainstay of heart-disease prevention and ...